Daniel Lee Flynn - Jun 16, 2022 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Chief Scientific Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Jun 16, 2022
Transactions value $
-$19,006
Form type
4
Date filed
6/21/2022, 04:34 PM
Previous filing
Feb 18, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$19K -1.77K -3.69% $10.75 46.1K Jun 16, 2022 Direct F1
holding DCPH Common Stock 230K Jun 16, 2022 By Daniel L. Flynn Revocable Trust
holding DCPH Common Stock 91K Jun 16, 2022 By Daniel L. Flynn Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.